INNOCOS SUMMIT ZURICH 2026
Longevity in Beauty, Wellness
& Across Consumer Brands

Five Zurich Hotel  •  September 9–11, 2026

Day 1 – Welcome & First Connections

The opening evening is designed for one purpose: to create the conditions for everything that follows.

18:00 – 19:30 - Welcome Drinks: The Longevity Edition

Welcome Reception  ·  Hosted by INNOCOS

  • Functional cocktails, adaptogenic mocktails and low-alcohol options designed for energy and focus
  • Ingredient stations featuring Swiss biotech formulations, nootropics and recovery compounds
  • Curated introductions and first conversations — no lanyards, no lectures
  • Exhibition preview: early access to tabletop brands and innovation partners

Day 2 – Brand Strategy, Commercial Models, Experience & The Future Consumer

MORNING ACTIVATION & EXHIBITION OPEN

Movement Session  ·  Optional

  • Guided mobility, posture and breath-led movement to activate body and mind
  • Designed for those who want to arrive energised, not caffeinated
  • Why Korea’s headspa culture is a window into the next global wellness trend
  • Hands-on experience of professional scalp diagnostics and ritual treatments
  • Understanding how scalp health is becoming the foundation of hair and skin longevity
  • A sensory experience that encodes the cultural intelligence behind K-Beauty’s success

OPENING & CONTEXT SETTING

Opening Remarks  ·  INNOCOS Founder

  • Why longevity has crossed from trend to infrastructure
  • Why Switzerland and Europe are uniquely positioned to lead this shift
  • The summit’s central questions: proof, trust, diagnostics, channel, and the art of building desire without diluting biology

Opening Keynote  ·  Irina Barbalova — Global Lead, Beauty and Wellness — Euromonitor

A macro view of how longevity is reshaping beauty, wellness, supplements, diagnostics and devices — and what the numbers actually say.

  • Where category convergence is real vs where it is narrative
  • The consumer segments driving growth, and where they live
  • The commercial implications for every subsequent session

10:00 – 10:30 Morning Break & Exhibition Access  ·  30 minutes

BRAND EQUITY BUILDING & CONSUMER FOCUS

Presentation  ·   Invited: Jasmin Goller — Vice President Marketing Europe & North America — Beiersdorf

Who is doing real biology versus rebranding older positioning with a new word, and why the distinction now shows up in valuations.

Presentation  ·  Invited: Emily McDonagh — Marketing Leader | Bansk Beauty | Home to amika, Byoma, Ethique — Bansk Beauty

The blurring of categories — and what it means for segmentation, messaging and channel selection.

Presentation  ·  Invited: Carrie Gross — Co-Founder & Chief Creative Officer — Dr Dennis Gross Skincare™

Ecosystems that combine diagnostics, products and tracking — where platform economics start to beat product economics.

Panel  ·   Invited: Jasmin Goller — Vice President Marketing Europe & North America — Beiersdorf

Honesty as a growth strategy. Label accuracy, ingredient transparency, and claim discipline under European regulation, and how to communicate real science without sounding clinical or cold.

Presentation  ·   Invited: Estee Lauder

Experience as a major brand-building tool — why the next generation of longevity brands is judged on moments, rituals and environments, not just SKUs.

13:00 – 14:20 Hosted Lunch & Exhibition Access  ·  1 hour 20 minutes

INTERACTIVE BRAINSTORMING WORKSHOP

Presentation  ·   Invited: Jasmin Goller — Vice President Marketing Europe & North America — Beiersdorf

Who is doing real biology versus rebranding older positioning with a new word, and why the distinction now shows up in valuations.

15:40 – 16:10 Afternoon Break & Exhibition Access  ·  30 minutes

INTERACTIVE BRAINSTORMING WORKSHOP

Presentation  ·   Invited: Unilever

The real founder question: where speed wins markets and where it destroys margin, credibility or clinical integrity.

Global Opportunity Session. Invited: Esther Moisy-Kirschbaum — Head of Content — Magma & Oblique Forecasting

A focus on ageing populations and the regional growth maps that actually drive the category over the next five years.

Panel   ·  Invited: Grace Vernon — Head of Boots Ignite, Foresight & Trends — Boots & No7 Beauty Company; Fernando Junoy — Member of the Executive Board — Pierre Fabre Laboratories, Jesse Pijpers — Head of Marketing Europe — David Lloyd Leisure

The honest channel audit — where profitable growth actually originates once you strip out paid acquisition noise.

Panel   · Inviting 

What signals make you lean in immediately? What kills a deal, even if growth looks good? Longevity: real value driver or just a narrative today?

Awards Ceremony  ·  45 minutes  ·  Presented by INNOCOS

  • Innovation of the Year
  • Scientific Translation Award
  • Rising Founder Recognition
  • Most Promising Clinic / Device / Formulation Platform
  • Audience Choice Award

Day 3 – Longevity Science  ·  Women's Health  ·  Clinics  ·  Diagnostics

LONGEVITY SCIENCE

Presentation  ·   Invited: Marie Renault — CMO — RoC Skincare

Science vs hype vs regulation — the honest state of the field, translated for commercial teams.

Presentation   · 

Translating biology into product strategy. Which hallmarks are actionable in consumer formats and which remain lab-only.

Panel/Presentation   ·   Invited: Luc Aguilar — CSO — L’Oréal

What serious clinical substantiation now looks like — and where studies are doing work for the marketing deck, not the consumer.

10:30 – 11:00 Morning Break & Exhibition Access  ·  30 minutes

 WOMEN'S HEALTH

Presentation   · 

Estrogen decline, cortisol, cycle-based changes — and the skincare strategy implications most brands still ignore.

Panel   · 

One of the biggest untapped categories in beauty. The commercial case, the science case and the product-architecture case.

Panel/Presentation   ·   Invited: Renata Batal — Global Marketing for Materna & Women’s Health — Nestlé

Most longevity research is historically male-focused. What changes when the category is built around female physiology from the first principles?

 CLINICS

Panel   ·  Invited: Omar Haroon — Founder — Plastic Surgeon

Are dermatologists and longevity clinicians replacing brands as the authority consumers trust most?

Panell Invited: Fernando Junoy — Member of the Executive Board — Pierre Fabre Laboratories

Co-created protocols where clinic and brand share outcomes, data and margin — and where the model breaks.

Panel   ·  Invited: 

The mechanics of trust transfer, what clinics can license credibly, and what brands must stop claiming when they partner.

10:30 – 11:00 Morning Break & Exhibition Access  ·  30 minutes

DIAGNOSTICS

Panel   · 

Imaging, AI and biomarkers — the technologies actually deployed in 2026, and what they change about product design.

Panel   ·  Invited: Anouschka Prettner — Head of Digital — Swissline Cosmetics / Dermalab SA

Trust in algorithms. What works, what is theatre, and what consumers can reasonably believe.

Closing Remarks  ·  INNOCOS Founder

  • Turning insight into action
  • From interest in longevity to building real businesses around it
  • What INNOCOS is building next — and how attendees can be part of it

ADDITIONAL SESSION CANDIDATES UNDER CURATION

  • Mitochondria, Senescence, Inflammaging: What Should Brands Own?
  • Topical vs Systemic Longevity: Where Does Skincare Stop?
  • Biomarkers of Skin Aging: Can We Finally Measure “Better Skin”?
  • From Ingredient Stories to Mechanism of Action
  • Cycle-Synced Beauty: Science or Overcomplication?
  • Fertility, Pregnancy, Postpartum: Redefining “Safe” Skincare
  • From Taboo to Category: Intimate, Internal and Holistic Care
  • Emotional & Mental Health as Skin Drivers
  • Injectables, Devices, Topicals: Who Owns the Outcome?
  • From Aesthetic to Preventative Clinics
  • Standardisation vs Art: Can Clinical Results Be Scaled?
  • At-Home vs In-Clinic: Where Is the Boundary Moving?
  • Can We Quantify Aging in Real Time?
  • At-Home Diagnostics: Opportunity or Data Noise?
  • Data Ownership: Who Controls Your Skin Data?
  • Closing the Loop: Diagnostics → Treatment → Measurable Outcomes
Skip to content